Sai Life Sciences Ltd

Sai Life Sciences Ltd Share Price Today: Live Updates & Key Insights

Get insights on Sai Life Sciences Ltd’s fundamentals, financials, shareholding, peer comparison, corporate actions & performance. Track key metrics, price trends & market sentiment for informed decisions. Explore all data at Motilal Oswal.

Sai Life Sciences Ltd Share Price Chart

Sai Life Sciences Ltd Fundamentals

Traded Volume: 1,19,760

Market Cap(Cr): 18,103

Avg Traded Price 862.63

1 Year return %

Upper Circuit 874.8

Lower Circuit 857

P/E TTM 63.00

P/B Ratio 14.00

Traded Value(Cr) 1031.55

EPS TTM 13.628

Book value 13.628

Dividend 0.00%

Sai Life Sciences Ltd Share Price Performance

Shows the percentage change in stock price over different time periods

This section highlights Sai Life Sciences Ltd stock price performance across key timeframes, including 1-week, 1-month, 3-month, Year-To-Date (YTD), and 1-year returns. It provides insights into the Sai Life Sciences Ltd share price history, short-term movements, long-term trends, and overall investor sentiment

1W -1.07%

1M -1.77%

3M -5.47%

1Y null%

YTD +15.29%

Sai Life Sciences Ltd Traded Volume Movement

Shows the trading volume over different time periods

This section highlights Sai Life Sciences Ltd daily and average traded volumes, offering insights into investor activity and market liquidity. Higher volumes than average often indicate rising interest, news impact, or shifting market sentiment

Yesterday 1.54L

Day Before Yesterday 89798.00

1W Avg 2.42L

1M Avg 3.80L

3M Avg 13.33L

Sai Life Sciences Ltd Technical Details

Sai Life Sciences Ltd technical indicators, such as support and resistance levels and pivot points, are calculated based on historical price and volume trends. These metrics help traders anticipate possible price movements and make informed trading decisions.

Support 1 854

Support 2 847

Support 3 836

Pivot Point : 864

Resistance 1 872

Resistance 2 882

Resistance 3 889

Sai Life Sciences Ltd Corporate Actions

Sai Life Sciences Ltd corporate actions include dividends, bonus issues, stock splits, and key company updates that may affect share price and investor sentiment. This section provides timely details on past and upcoming actions, including ex-date, record date, and payout ratio - helping investors make informed decisions based on Sai Life Sciences Ltd’s capital allocation strategies.

All

Dividends

No Dividend has been declared by SAILIFE

Bonus

No Bonus has been declared by SAILIFE

Splits

No Split has been declared by SAILIFE

Others

Rights No Rights has been declared by SAILIFE

Sai Life Sciences Ltd Peer Comparison

Shows key financial metrics for the company and its peers

This section compares Sai Life Sciences Ltd with leading peers in the banking sector based on key metrics such as market capitalization, 1-year return, P/E (TTM), and PB ratio. It helps investors evaluate Sai Life Sciences Ltd's relative performance and valuation against major competitors.

Stock Name Wockhardt Ltd ₹1311.30 (-1.04%) M. Cap (Cr) 213.08 1 Yr Return (%) +11.63% P/E (TTM) -926.42 PB Ratio 6.27

Stock Name Neuland Laboratories Ltd ₹16598.00 (-0.72%) M. Cap (Cr) 212.95 1 Yr Return (%) +12.39% P/E (TTM) 88.68 PB Ratio 15.26

Stock Name OneSource Specialty Pharma Ltd ₹1630.40 (-2.51%) M. Cap (Cr) 186.78 1 Yr Return (%) NaN% P/E (TTM) 467.37 PB Ratio 3.18

Stock Name Sai Life Sciences Ltd ₹861.35 (-1.44%) M. Cap (Cr) 181.03 1 Yr Return (%) NaN% P/E (TTM) 63.21 PB Ratio 18.71

Stock Name Alembic Pharmaceuticals Ltd ₹901.00 (+0.17%) M. Cap (Cr) 177.10 1 Yr Return (%) -13.19% P/E (TTM) 27.92 PB Ratio 3.41

Stock Name Jubilant Pharmova Ltd ₹1057.80 (-2.06%) M. Cap (Cr) 168.51 1 Yr Return (%) -6.42% P/E (TTM) 35.27 PB Ratio 2.84

Stock Name Natco Pharma Ltd ₹864.80 (-0.52%) M. Cap (Cr) 154.89 1 Yr Return (%) -37.09% P/E (TTM) 10.07 PB Ratio 2.04

Sai Life Sciences Ltd Cash Flow

Cash flow data provides a view of how money is generated and spent by Sai Life Sciences Ltd, across its operating activities, investing activities, and financing activities.

PARTICULARS Operating Activities Mar 2025 330.35 Mar 2024 250.64 Mar 2023 221.47 Mar 2022 88.38 Mar 2021 -25.94

PARTICULARS Investing Activities Mar 2025 -564.71 Mar 2024 -190.05 Mar 2023 -111.23 Mar 2022 -94.63 Mar 2021 -279.46

PARTICULARS Financing Activities Mar 2025 314.31 Mar 2024 -84.63 Mar 2023 -190.04 Mar 2022 80.95 Mar 2021 303.58

PARTICULARS Net Cash Flow Mar 2025 79.95 Mar 2024 -24.04 Mar 2023 -79.80 Mar 2022 74.70 Mar 2021 -1.81

Sai Life Sciences Ltd Shareholding Pattern

This shows the ownership breakdown of Sai Life Sciences Ltd, highlighting participation from Foreign Institutional Investors (FII), Mutual Funds, Public, Other Institutions, and Promoters.

Promoter 34.93%

Public 12.65%

Other Institutions 3.79%

FII 22.49%

Mutual Funds 26.16%

About Sai Life Sciences Ltd

Sai Life Sciences Limited was originally incorporated as `Sai Dru Syn Laboratories Limited' as a Public Limited Company, dated January 25, 1999, issued by the Registrar of Companies, Andhra Pradesh at Hyderabad. The Company received the Certificate of Commencement of Business from Registrar of Companies, Andhra Pradesh on February 17, 1999. Subsequently, the Company name was changed from `Sai Dru Syn Laboratories Limited' to `Sai Life Sciences Limited' dated December 16, 2003.Thereafter, the name of the Company was changed from `Sai Life Sciences Limited' to `Sai Advantium Pharma Limited' dated August 30, 2006 issued by the Registrar of Companies, Andhra Pradesh. Subsequently, the Company name was changed from `Sai Advantium Pharma Limited' to `Sai Life Sciences Limited' and a fresh Certificate of Incorporation dated May 28, 2012 was issued by the Registrar of Companies, Andhra Pradesh at Hyderabad.The Company is an innovator-focused contract research, development, and manufacturing organization (CRDMO). The Company provide end-to-end services across the drug discovery, development and manufacturing value chain, for small molecule NCE to global pharmaceutical innovators companies and biotechnology firms. It possess both (a) discovery / contract research and (b) CMC / CDMO capabilities.Through the Scheme of Amalgamation, Prasad Drugs Limited was merged into the Company in 2004. The Company acquired Merrifield Pharma Private Limited in 2006. Later, the Company opened new areas of biology facility in Watertown (Greater Boston, MA) U.S.A. for innovative and creative small-molecule drugs in 2019. It launched Sai Nxt, an initiative to transform the organization into a new generation CDMO in 2020. It further added cellular analysis platforms at its discovery biology facility in Cambridge, Massachusetts, USA.In 2021, the Company opened a new discovery biology facility at Unit II Plant in Hyderabad. In 2022, it opened the first set of new disconvery chemistry labs at Unit III Plant, Hyderabad. In 2023, the Company opened high potency API manufacturing block at Unit IV Bidar Facility and has launched a dedicated Peptide Research Center at Unit II at Hyderabad in FY 2025. The Company raised funds aggregating Rs 3042.6 Crore by issuing 55,421,123 equity shares of face value of Re 1 each, comprising a fresh issue of 17,304,189 equity shares amounting to Rs 950 Cr and 38,116,934 equity shares amounting to Rs 2092.62 Cr in December 2024.

Chairman & Exec. Director

Ranga Raju Kanumuri

Registered office Plot #.DS-7 IKP Knowledge Park, Turkapally (V) Shameerpet Md, Hyderabad, Telangana, 500078

FAX :+91 40 6815 6000

Background

Incorporation Year 1999

Face Value ₹1.00

Market Lot 1

Sai Life Sciences Ltd Latest News

VIEW MORE NEWS

FAQs on Sai Life Sciences Ltd